Right now, patient access to medicinal cannabis is under serious pressure.
AHPRA has established a rapid response taskforce targeting medicinal cannabis prescribers. At the same time, the TGA is reviewing medicinal cannabis policy, with decisions that could shape patient care for years to come.
Leaders across Australia’s health system must ensure agencies like the TGA and AHPRA act fairly and in the best interests of patients.
Yet many of the most urgent problems facing this sector are not being addressed. Patients are experiencing uncertainty and extended waiting periods for their medicine.
By ...
Right now, patient access to medicinal cannabis is under serious pressure.
AHPRA has established a rapid response taskforce targeting medicinal cannabis prescribers. At the same time, the TGA is reviewing medicinal cannabis policy, with decisions that could shape patient care for years to come.
Leaders across Australia’s health system must ensure agencies like the TGA and AHPRA act fairly and in the best interests of patients.
Yet many of the most urgent problems facing this sector are not being addressed. Patients are experiencing uncertainty and extended waiting periods for their medicine.
By emailing our leaders today, you can help ensure the people most affected, The Patients, are heard.
Every message matters in putting patient needs back at the centre of policy.
Add your voice before 7 October, 2025.
AHPRA’s Rapid Response Taskforce is targeting prescribers.
The TGA is reviewing policy, with decisions that may change access for years.
Some patients are aleady facing uncertainty and delays.
Many urgent problems are being ignored.
Our mission: 10,000 patient emails sent by 7 October 2025.
Take action: Email our leaders today and make sure patient voices are heard.
Deadline: 7 October 2025.
Hands up if you want whole-plant medicines to remain available?